We have demonstrated that KD alleviates 17α-ethinylestradiol-induced cholestatic liver injury in rats, the underlying mechanism of which may be due to the inhibition of inflammatory responses and regulation of FXR-mediated bile acid homeostasis. The gene discussed is NR1H4; the disease is medical procedure.